Solstein Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-25,000
Closed -$3K 38
2019
Q1
$3K Buy
25,000
+21,100
+541% +$3.73M 0.02% 37
2018
Q4
$2K Hold
3,900
0.01% 32
2018
Q3
$10K Hold
3,900
0.06% 33
2018
Q2
$28K Hold
3,900
0.13% 35
2018
Q1
$631M Buy
+3,900
New +$621K 6.24% 8

Other funds holding CME

Solstein Capital's CME Position: Q1 2026 in Review

Solstein Capital increased its CME Group (CME) stake by 30% in Q1 2026, buying an estimated $93.9K and bringing the position to 1,359 shares worth $401K. The position accounts for 0.16% of the portfolio, ranked #97.

Solstein Capital first reported a position in CME in Q1 2018 and has held it in 30 quarters since. The position peaked at $644K in Q2 2018. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Solstein Capital held 1,359 shares of CME Group worth $401K as of Q1 2026.
  • Solstein Capital bought 316 CME Group shares in Q1 2026, an estimated $93.9K.
  • CME Group made up 0.16% of Solstein Capital's portfolio in Q1 2026, its #97 holding.
  • Solstein Capital first reported a position in CME Group in Q1 2018 and has held it in 30 quarters since.
  • Solstein Capital's CME Group position peaked at $644K in Q2 2018.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.